Tempus AI, Inc.
TEMAPI behind this page
TEM FY 2025 request
Playground key active
/api/financials?ticker=TEM&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 1,271,789 | 693,398 | +83.4% |
Show Product Lines breakouts |
|||
| AI Applications [Member] | 20.1 | 12.3 | +63.4% |
| Clinical Order [Member] · Third Party Payor | 884.5 | 409.4 | +116.0% |
| Data and applications [Member] | 316,408 | 241,649 | +30.9% |
| Diagnostics [Member] | 955,381 | 451,749 | +111.5% |
| Diagnostics [Member] · Ambry [Member] | 362.7 | — | — |
| Genomics Product [Member] · Self Pay | 70.9 | 42.3 | +67.6% |
| Insights Product [Member] | 257.7 | 186.8 | +38.0% |
| Trials Product [Member] | 38.5 | 42.4 | -9.2% |
Show Business Acquisition breakouts |
|||
| Paige.AI, Inc. [Member] | 4.6 | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 65,251 | 4,502 | +1349.4% |
| SB Tempus Corp [Member] · Data License Agreement [Member] | 25 | 16.6 | +50.6% |
| Cost of Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Data and applications [Member] | 87,790 | 68,818 | +27.6% |
| Diagnostics [Member] | 386,102 | 243,467 | +58.6% |
| Technology Research And Development Expenses | 146,107 | 167,519 | -12.8% |
| Research & Development | 172,924 | 149,325 | +15.8% |
| Selling, General & Administrative | 731,738 | 755,351 | -3.1% |
| Total Costs & Expenses | 1,524,661 | 1,384,480 | +10.1% |
| Operating Income | -252,872 | -691,082 | +63.4% |
| Interest Income | 12,628 | 11,084 | +13.9% |
| Interest Expense Debt | -70,267 | -53,653 | -31.0% |
| Gains Losses On Extinguishment Of Debt | -12,034 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Term Loans | 12 | — | — |
| Other Non-Operating Income (Expense) | 31,447 | 32,336 | -2.7% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -291,098 | -701,315 | +58.5% |
| Income Tax Expense (Benefit) | 51,684 | -266 | +19530.1% |
Show Business Acquisition breakouts |
|||
| Ambry [Member] | 52.7 | — | — |
| Income Loss From Equity Method Investments | -5,614 | -4,228 | -32.8% |
| Net Income | -245,028 | -705,809 | +65.3% |
Show Equity Components breakouts |
|||
| Retained Earnings | -245,028 | -705,809 | +65.3% |
Show Business Acquisition breakouts |
|||
| Ambry [Member] | 1.8 | — | — |
| Paige.AI, Inc. [Member] | 2.2 | — | — |
| Net Income Loss Available To Common Stockholders Basic | -245,028 | -746,330 | +67.2% |
| Net Income Loss Available To Common Stockholders Diluted | -245,028 | -746,330 | +67.2% |
| EPS (Basic) | -1.41 | -6.23 | +77.4% |
| EPS (Diluted) | -1.41 | -6.23 | +77.4% |
| Wtd Avg Shares (Basic) | 174,264 | 119,849 | +45.4% |
| Wtd Avg Shares (Diluted) | 174,264 | 119,849 | +45.4% |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 808 | 89 | +807.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 808 | 89 | +807.9% |
| Comprehensive Income | -244,220 | -705,720 | +65.4% |
| Revenue (FY) | — | — | — |
Show Period [Axis] breakouts |
|||
| Twelve Months Ended Thirty First Of December Two Thousand And Twenty Five [Member] · Term Loans | 1 | — | — |
| Twelve Months Ended Thirty First Of December Two Thousand And Twenty Six [Member] · Term Loans | 1.1 | — | — |
| Labor And Related Expense | 276,208 | 162,194 | +70.3% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 604,787 | 340,954 | +77.4% |
| Accounts Receivable | 311,170 | 154,819 | +101.0% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 6,428 | 4,287 | +49.9% |
| Inventory | 51,724 | 38,386 | +34.7% |
| Other Receivables Net Current | 8,785 | — | — |
| Prepaid Expenses & Other Current Assets | 40,498 | 26,135 | +55.0% |
| Equity Securities Fv Ni | 150,211 | 107,309 | +40.0% |
| Total Current Assets | 1,167,175 | 667,603 | +74.8% |
Show Related Party Transactions By Related Party breakouts |
|||
| Pathos [Member] | 8.8 | 0 | — |
| Non-Current Assets | |||
| Property, Plant & Equipment | 89,156 | 58,056 | +53.6% |
| Goodwill | 470,211 | 73,343 | +541.1% |
| Related Party Asset Noncurrent | 16,215 | — | — |
| Operating Lease Right-of-Use Assets | 64,496 | 14,762 | +336.9% |
| Restricted Cash Noncurrent | 4,664 | 881 | +429.4% |
| Total Assets | 2,274,838 | 926,116 | +145.6% |
| Intangible Assets | 355,234 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Capitalized Software [Member] | 6,051 | — | — |
| Customer Relationships | 205,828 | 4,944 | +4063.2% |
| Developed Technology - Biotech [Member] | 93,100 | — | — |
| Developed Technology - Software [Member] | 12,500 | — | — |
| Licensed data [Member] | 5,647 | 2,182 | +158.8% |
| Trade Names | 32,108 | 4,571 | +602.4% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill Net Of Amortization And Impairment Charges | 355,253 | 11,716 | +2932.2% |
| Investments And Other Noncurrent Assets | 21,111 | 8,305 | +154.2% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 86,557 | 91,450 | -5.4% |
| Current Liabilities | |||
| Accounts Payable | 81,994 | 53,804 | +52.4% |
| Accrued Liabilities | 155,370 | 130,407 | +19.1% |
| Deferred Revenue (Current) | 92,673 | 75,981 | +22.0% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 3,938 | 0 | — |
| Contract With Customer Liability Other | 15,955 | 15,955 | 0.0% |
| Other Liabilities Current | 8,680 | 6,964 | +24.6% |
| Operating Lease Liability Current | 13,355 | 6,459 | +106.8% |
| Accrued Licensing Data Fees Current | 4,361 | 1,500 | +190.7% |
| Total Current Liabilities | 372,388 | 291,070 | +27.9% |
| Interest Payable Non Current | 12,393 | 70,450 | -82.4% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 74,272 | 26,199 | +183.5% |
| Convertible Debt Noncurrent | 208,672 | 168,192 | +24.1% |
| Other Non-Current Liabilities | 56,600 | 15,980 | +254.2% |
| Contract With Customer Liability Other Noncurrent | 7,977 | 23,932 | -66.7% |
| Contract With Customer Liability Noncurrent | 20,379 | 6,710 | +203.7% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 0 | — | — |
| Total Liabilities | 1,783,512 | 869,777 | +105.1% |
| Other Liabilities | |||
| Line Of Credit | 100,000 | — | — |
| Long Term Loans Payable | 202,753 | 267,244 | -24.1% |
| Convertible Senior Notes Net | 728,078 | — | — |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show Statement Class Of Stock breakouts |
|||
| Common Class A | 17 | 16 | +6.2% |
| Common Class B | 1 | 1 | 0.0% |
| Treasury Stock Common Value | -6,642 | -3,602 | -84.4% |
| Additional Paid In Capital Common Stock | 2,892,910 | 2,210,664 | +30.9% |
| Accumulated Other Comprehensive Income | 902 | 94 | +859.6% |
| Retained Earnings | -2,395,862 | -2,150,834 | -11.4% |
| Total Stockholders' Equity | 491,326 | 56,339 | +772.1% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 902 | 94 | +859.6% |
| Additional Paid In Capital | 2,892,910 | 2,210,664 | +30.9% |
| Common Stock · Common Class A | 17 | 16 | +6.2% |
| Common Stock · Common Class B | 1 | 1 | 0.0% |
| Retained Earnings | -2,395,862 | -2,150,834 | -11.4% |
| Treasury Stock Common | -6,642 | -3,602 | -84.4% |
| Total Liabilities & Equity | 2,274,838 | 926,116 | +145.6% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Stock-Based Compensation | 124,747 | 534,138 | -76.6% |
| Equity Securities Fv Ni Gain Loss | -16,471 | -12,110 | -36.0% |
| Gain Loss On Sale Of Property Plant Equipment | 415 | — | — |
| Deferred Income Taxes | -52,665 | — | — |
| Amortization Of Debt Discount Premium | 4,088 | 1,382 | +195.8% |
Show Long-Term Debt Type breakouts |
|||
| Convertible Senior Notes [Member] | 2.3 | — | — |
| Amortization of Financing Costs | 484 | 510 | -5.1% |
| Business Combination Contingent Consideration Arrangements Change In Fair Value Of Holdback Liability | -1,337 | — | — |
| Depreciation Of Tangible Assets And Amortization Of Intangible Assets | 102,324 | 37,245 | +174.7% |
| Provision For Doubtful Accounts | 2,558 | 680 | +276.2% |
| Provision For Obsolete Inventory | 1,335 | — | — |
| Operating Lease Right Of Use Asset Amortization Expense | 11,554 | 6,047 | +91.1% |
| Accretion Expense | 268 | 197 | +36.0% |
| Paid In Kind Interest | 10,537 | 8,811 | +19.6% |
| Change in Accounts Receivable | -90,402 | -61,037 | -48.1% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | -2,141 | -4,203 | +49.1% |
| Change in Inventory | -3,369 | -9,541 | +64.7% |
| Change in Prepaid & Other Assets | -1,699 | -13,683 | +87.6% |
| Increase Decrease In Investments And Other Current Assets | -17,301 | -751 | -2203.7% |
| Change in Accounts Payable | -7,241 | -23,852 | +69.6% |
| Increase Decrease In Due From Related Parties | -25,000 | — | — |
| Change in Deferred Revenue | -6,960 | -20,942 | +66.8% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 3,938 | 0 | — |
| Increase Decrease In Contract With Customer Liability Other | -15,955 | 39,887 | -140.0% |
| Increase Decrease In Accrued Data Licensing Fees | 2,966 | -5,000 | +159.3% |
| Increase Decrease In Other Accrued Liabilities | -12,844 | 50,540 | -125.4% |
| Increase Decrease In Interest Payable Net | 14,206 | 15,129 | -6.1% |
| Increase Decrease In Operating Lease Liability | -14,948 | -8,553 | -74.8% |
| Net Cash from Operations | -218,090 | -189,045 | -15.4% |
| Investing Activities | |||
| Capital Expenditures | -21,049 | -22,121 | +4.8% |
| Proceeds From Sale Of Equity Securities Fv Ni | 8,316 | 23,098 | -64.0% |
Show Financial Instrument breakouts |
|||
| Investment In Recursion Pharmaceuticals Class A Common Stock [Member] | 8.3 | 23.1 | -64.1% |
| Payments To Acquire Marketable Securities | -2,740 | -36,183 | +92.4% |
| Payments To Acquire Businesses Net Of Cash Acquired | -376,666 | — | — |
| Payments To Acquire Software | -6,216 | — | — |
| Net Cash from Investing | -398,355 | -130,392 | -205.5% |
| Redemption Of Convertible Promissory Note | 32,008 | 24,932 | +28.4% |
| Deferred Offering Costs Accrued But Not Yet Paid | 47 | — | — |
| Deferred Financing Fees Accrued But Not Yet Paid | 226 | — | — |
| Reclassification Of Deferred Offering Costs To Additional Paid In Capital Upon At The Market Offering | 821 | — | — |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 22,670 | 1,997 | +1035.2% |
| Voting Common Stock Issued In Connection With Business Combinations | 403,154 | — | — |
| Voting Common Stock Issued In Connection With License Agreement | 1,443 | — | — |
| Convertible Promissory Note Principal Reset Due To Amendment | 72,488 | — | — |
| Financing Activities | |||
| Payments For Repurchase Of Equity | -3,040 | — | — |
| Debt Issuance Costs | -806 | -8,766 | +90.8% |
| Proceeds From Revolving Credit Facility Net Of Issuance Costs | 98,000 | — | — |
| Proceeds From Debt Net Of Issuance Costs | 196,000 | — | — |
| Proceeds From Convertible Debt | 726,497 | — | — |
| Payment Of Deferred Financing Fees | -1,519 | — | — |
| Repayments Of Long Term Debt | -276,892 | — | — |
| Payments Of Debt Extinguishment Costs | -7,841 | — | — |
| Purchases Of Capped Call | -41,775 | — | — |
| Proceeds From Issuance Of Common Stock In Connection With At The Market Offering Net Of Commissions | 195,499 | — | — |
| Net Cash from Financing | 884,123 | 494,329 | +78.9% |
| Supplemental | |||
| Interest Paid | 44,031 | 28,045 | +57.0% |
Show Long-Term Debt Type breakouts |
|||
| Term Loans | 44 | — | — |
| Income Taxes Paid | 654 | 206 | +217.5% |
| Marketable Equity Securities Received On Accounts Receivable | 32,000 | 22,000 | +45.5% |
| Unpaid Capital Expenditures | 5,535 | 4,292 | +29.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -62 | 336 | -118.5% |
| Net Change in Cash | 267,616 | 175,228 | +52.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 609,451 | 341,835 | +78.3% |
| Restricted Cash And Cash Equivalents | 4,664 | 881 | +429.4% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.